Researchers at IISc develop low frequency ultrasound technology to selectively treat stage 4 oral cancer

Image for Researchers at IISc develop low frequency ultrasound technology to selectively treat stage 4 oral cancer

A tumour just met its weak spot — and it's not a drug, it's sound.

Scientists at IISc Bengaluru have found that Stage 4 oral cancer cells can be selectively destroyed using low-frequency ultrasound, while healthy cells around them barely notice.

No chemo. No radiation. Just vibration.

Stay with me.

Oral cancer isn't rare in India.

We account for roughly 1 in 4 of all cases globally — mostly driven by chewable tobacco.

And survival odds here are brutal:

  • 🇮🇳 50% five-year survival rate in India
  • 🌍 68% in developed nations

That gap is the whole reason this discovery matters.


🔬 So how do you "sound-bomb" a tumour?

Researchers, working with MS Ramaiah Medical College, built a 3D lab model that mimics a real tumour — cancer cells wrapped in a protective barrier that normally keeps drugs out.

Then they hit it with Low Frequency Ultrasound (LFU).

The result, tested on samples from 15 Stage 4 patients?

Cancer cells collapsed.

Healthy cells stayed standing.

Every single time.

PhD student Rashmita Luha, the study's first author, said what surprised the team most was the consistency — patients, stages, tumours all differed, but the response didn't.


🧬 The missing protein that gives cancer away

Here's the twist.

Normal cells carry a protein called Tropomyosin 2.1 — think of it as structural armour against physical stress.

Cancer cells lose most of it.

So when LFU shakes things up, healthy cells shrug it off.

Cancer cells simply can't hold together.

⚡ No armour. No survival.


🩺 Why this isn't a magic cure yet

High-frequency ultrasound (the imaging kind) barely penetrates a few centimetres.

HIFU — the heat-based version used for prostate cancer — works, but burns tissue and carries side effects.

LFU is different: gentler, deeper reach, selective kill.

But surgeons are already flagging a real concern — applying pressure to a tumour risks spilling cancer cells into nearby tissue, which is exactly what neck dissections are designed to prevent.

So this needs careful clinical validation before it reaches a hospital bed.


🚀 Bigger than one cancer

IISc has already patented the tech.

And because it works best on tumours near the surface, researchers say breast cancer and melanoma could be next in line.

A tiny protein deficiency, discovered in a lab dish, might just rewrite how we fight some of the world's toughest cancers.

That's all for now!